Hutch News
Results per Page:
New program to fast-track lung cancer research from lab to clinic
Patient-focused science at the heart of $13M National Cancer Institute grant
Seattle mayor and melanoma survivor Jenny Durkan visits Fred Hutch
Mayor shares personal story as Hutch scientists outline the future of cancer therapy
His immune system eradicated his melanoma. Could other patients’ bodies be taught to do the same thing?
How one man’s T cells are guiding the development of next-gen immunotherapies
7 skin cancer myths — debunked
Experts take on base tans and other ‘complete baloney’ standing in the way of skin health
Forum at Fred Hutch focuses on the hottest developments in cancer immunotherapy
Immune-based treatments move from the fringes to the spotlight
Good News: Malik and Bloom win ASM awards; pilot project funded by Bezos family aims to create personalized anticancer vaccines
Celebrating faculty and staff achievements
Tailoring immune cells to target leukemia
Promising early trial results show engineered immune cells may help buffer against cancer relapse after bone marrow transplantation
Fred Hutch staff, scientists participate in Life Sciences Research Weekend
Hutch scientists demo flu science, evolution at Pacific Science Center event